Non-selective Cannabinoids
Non-selective Cannabinoid Agonists |
|
|---|---|
| Cat. No. | Product Name / Activity |
| 3381 | AM 1172 |
| CB receptor partial agonist; also anandamide uptake inhibitor and FAAH inhibitor | |
| 1339 | Anandamide |
| Endogenous and non-selective CB agonist | |
| 1298 | 2-Arachidonylglycerol |
| Endogenous and non-selective CB agonist; potent GPR55 agonist | |
| 3021 | Cannabigerol |
| Cannabinoid receptor partial agonist | |
| 3130 | Cannabinol |
| Cannabinoid receptor agonist; not psychoactive | |
| 2928 | CB 13 |
| Potent dual CB1/CB2 agonist | |
| 0966 | HU 210 |
| Highly potent cannabinoid receptor agonist | |
| 1038 | WIN 55,212-2 mesylate |
| Selective high affinity CB2 agonist | |
Non-selective Cannabinoid Antagonists |
|
| Cat. No. | Product Name / Activity |
| 1570 | (-)-Cannabidiol |
| Natural cannabinoid; GPR55 antagonist, weak CB1 antagonist, CB2 inverse agonist and AMT inhibitor | |
Neurodegeneration Research Product Guide
Our Neurodegeneration guide highlights over 275 products for neurodegeneration research.
Request copyRequest PDFPain Research Product Guide
Our Pain guide highlights over 280 products for Pain research.
Request copyRequest PDFCannabinoid Scientific Review
Our Cannabinoid review gives an overview of the pharmacological ligands used to study the cannabinoid CB1 and CB2 receptors.
Request copyRequest PDF